Safety Profile of Pembrolizumab Monotherapy Based on an Aggregate Safety Evaluation of 8937 Patients
EUROPEAN JOURNAL OF CANCER(2024)
Key words
Safety,Pembrolizumab,Programmed cell death 1 receptor,Neoplasms
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined